Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow LIFECORE BIOMEDICAL, INC. DE

Get SEC filing alerts via email and in your feed for LIFECORE BIOMEDICAL, INC. DE

LFCR

LIFECORE BIOMEDICAL, INC. DE

About LIFECORE BIOMEDICAL, INC. DE

Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceuticals and medical devices. It produces hyaluronic acid and viscous non-HA products, offering formulation, aseptic filling, and supply chain services across global markets. The company leverages proprietary fermentation, advanced manufacturing, and regulatory expertise to serve biopharmaceutical and biotech clients with high-quality, complex injectable solutions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from LIFECORE BIOMEDICAL, INC. DE

1
1
LIFECORE BIOMEDICAL, INC. DE Lifecore Biomedical Reports 34% Revenue Decline and $15M Net Loss for March 2026 Quarter

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
LIFECORE BIOMEDICAL, INC. DE Lifecore Biomedical Reports 26% Revenue Growth and Improved Gross Profit for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

3
1
LIFECORE BIOMEDICAL, INC. DE Lifecore Biomedical Reports $128.9 Million Revenue for Fiscal Year Ending May 2025

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
LIFECORE BIOMEDICAL, INC. DE Lifecore Biomedical Reports Decline in Financial Performance for Third Quarter and Nine Months Ended February 23, 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

5
1
LIFECORE BIOMEDICAL, INC. DE Lifecore Biomedical Reports 8% Revenue Growth to $32.6 Million, Faces $6.6 Million Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

6
1
LIFECORE BIOMEDICAL, INC. DE LifeCore Biomedical Reports Mixed Q3 Results with 1% Revenue Growth and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments